Detalhe da pesquisa
1.
Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial.
BMC Med
; 22(1): 78, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378570
2.
Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial.
Heliyon
; 10(5): e27370, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38463808
3.
Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial.
Vaccines (Basel)
; 11(2)2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851334
4.
Phase II, Safety and Immunogenicity of RAZI Cov Pars (RCP) SARS Cov-2 Vaccine in Adults Aged 18-70 Years; A Randomized, Double-Blind Clinical Trial.
J Pharm Sci
; 112(12): 3012-3021, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37832918
5.
Evaluation of cellular and humoral immune response in chickens immunized with flagellin-adjuvanted inactivated newcastle disease virus.
Comp Immunol Microbiol Infect Dis
; 85: 101796, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395519
6.
Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models.
Front Immunol
; 13: 836745, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35693788
7.
Evaluation of Outer Membrane Vesicles Obtained from Predominant Local Isolate of Boredetella pertussis as a Vaccine Candidate.
Iran Biomed J
; 25(6): 399-407, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34719226
8.
Development of specific nanobodies (VHH) for CD19 immuno-targeting of human B-lymphocytes.
Iran J Basic Med Sci
; 21(5): 455-464, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29922424